Chan Titus, Thiagarajan Ravi R, Frank Deborah, Bratton Susan L
Department of Pediatrics, Division of Pediatric Critical Care, Primary Children's Medical Center, University of Utah, Salt Lake City, Utah 84158-1289, USA.
J Thorac Cardiovasc Surg. 2008 Oct;136(4):984-92. doi: 10.1016/j.jtcvs.2008.03.007.
We investigated survival and predictors of mortality for infants and children with heart disease treated with extracorporeal membrane oxygenation as an aid to cardiopulmonary resuscitation.
Children (<18 years) with heart disease who received extracorporeal cardiopulmonary resuscitation and were reported to the Extracorporeal Life Support Organization database were evaluated. Patients were classified into one of 3 groups based on underlying cardiac physiology: single ventricle, 2 ventricles, and cardiac muscle disease. Patients with eligible procedure codes were assigned a Risk Adjustment for Congenital Heart Surgery-1 classification.
Four hundred ninety-two patients were eligible for analysis, and 279 (57%) were assigned a Risk Adjustment for Congenital Heart Surgery-1 category. Overall survival was 42%. In a multivariable logistic regression analysis, significant pre-extracorporeal predictors for mortality included single-ventricle physiology (odds ratio, 1.6; 95% confidence interval, 1.05-2.4), a history of a stage 1-type procedure (odds ratio, 2.7; 95% confidence interval, 1.2-6.2), and extreme acidosis (arterial blood gas pH < 7.01; odds ratio, 2.2; 95% confidence interval, 1.3-3.7). Right carotid artery cannulation was associated with decreased mortality risk (odds ratio, 0.6; 95% confidence interval, 0.4-0.9). During extracorporeal support, complications, including renal injury, evidence of neurologic injury, and persistent acidosis, were associated with an increased risk of hospital mortality.
Use of extracorporeal membrane oxygenation as an adjunct to cardiopulmonary resuscitation resulted in hospital survival in 42% of infants and children with heart disease. Underlying cardiac physiology and associated cardiac surgical procedures influenced mortality, as did pre-extracorporeal resuscitation status and extracorporeal membrane oxygenation-associated complications.
我们调查了接受体外膜肺氧合作为心肺复苏辅助手段治疗的心脏病婴幼儿及儿童的生存率和死亡预测因素。
对患有心脏病且接受体外心肺复苏并上报至体外生命支持组织数据库的18岁以下儿童进行评估。根据潜在心脏生理状况将患者分为3组之一:单心室、双心室和心肌病。为有符合条件手术编码的患者指定先天性心脏病手术风险调整-1分类。
492例患者符合分析条件,其中279例(57%)被指定为先天性心脏病手术风险调整-1类别。总体生存率为42%。在多变量逻辑回归分析中,体外膜肺氧合前显著的死亡预测因素包括单心室生理状况(比值比,1.6;95%置信区间,1.05 - 2.4)、1期手术史(比值比,2.7;95%置信区间,1.2 - 6.2)和极度酸中毒(动脉血气pH < 7.01;比值比,2.2;95%置信区间,1.3 - 3.7)。右颈动脉插管与降低死亡风险相关(比值比,0.6;95%置信区间,0.4 - 0.9)。在体外支持期间,包括肾损伤、神经损伤证据和持续性酸中毒在内的并发症与医院死亡风险增加相关。
使用体外膜肺氧合作为心肺复苏的辅助手段,使42%的心脏病婴幼儿及儿童获得了医院生存。潜在心脏生理状况和相关心脏手术程序影响死亡率,体外膜肺氧合前的复苏状态和与体外膜肺氧合相关的并发症也有影响。